BMP4 and glioblastoma: However, to the best of our knowledge, there is only one active phase I clinical trial for the treatment of adults with progressive and/or multiple recurrent GBM, in which human recombinant BMP4 is being administered through intratumoral and interstitial convection-enhanced delivery (CED) (NCT02869243) (reviewed in [24]).